Validation of Plasmodium vivax centromere and promoter activities using Plasmodium yoelii.
Plasmodium vivax is the leading cause of malaria outside Africa and represents a significant health and economic burden on affected countries. A major obstacle for P. vivax eradication is the dormant hypnozoite liver stage that causes relapse infections and the limited antimalarial drugs that clear...
Saved in:
| Main Authors: | Kittisak Thawnashom, Miho Kaneko, Phonepadith Xangsayarath, Nattawat Chaiyawong, Kazuhide Yahata, Masahito Asada, John H Adams, Osamu Kaneko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2019-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0226884&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plasmodium vivax Transmission in Africa.
by: Rosalind E Howes, et al.
Published: (2015-11-01) -
Comparative genomics of Plasmodium yoelii nigeriensis N67 and N67C: genome-wide polymorphisms, differential gene expression, and drug resistance
by: Jian Wu, et al.
Published: (2024-11-01) -
Risk factor for gametocyte carriage and gametocytemia in Plasmodium vivax and Plasmodium falciparum
by: Minxi Li, et al.
Published: (2025-08-01) -
Advances in transmission-blocking vaccines against Plasmodium falciparum and Plasmodium vivax
by: Mayumi Tachibana, et al.
Published: (2025-12-01) -
Why is Plasmodium vivax a neglected tropical disease?
by: Jane M Carlton, et al.
Published: (2011-06-01)